Diebold Nixdorf, Incorporated (DBD) Rises As Market Takes a Dip: Key Facts

Diebold Nixdorf (DBD) outperformed the market in the latest session, rising 1.13% against the S&P 500's 0.84% decline, and is up 4.07% over the past month. The company's upcoming earnings are expected to show an EPS of $0.61, a 47.41% decrease year-over-year, and revenue of $886.1 million, a 5.7% decrease year-over-year, though full-year estimates predict EPS of $3.57 and revenue of $3.81 billion, representing increases of 57.27% and 1.6%, respectively; the stock currently holds a Zacks Rank of #3 (Hold) and trades at a forward P/E of 14.4, a discount to its industry average.

Analysis

Diebold Nixdorf, Incorporated (DBD) demonstrated notable resilience in the latest trading session, closing at $51.98 with a 1.13% increase, a move that outpaced the S&P 500's 0.84% loss, the Dow's 0.7% decline, and the Nasdaq's 0.91% drop. This positive momentum extends over the past month, during which DBD's stock has risen by 4.07%, significantly outperforming the Computer and Technology sector's flat performance and the S&P 500's 1.44% gain. Investor focus is now on the upcoming earnings release, where consensus estimates anticipate an EPS of $0.61, marking a substantial 47.41% decrease compared to the same quarter last year, alongside expected revenue of $886.1 million, a 5.7% year-over-year decline. Conversely, full-year Zacks Consensus Estimates project a more favorable outlook, with earnings of $3.57 per share (a 57.27% increase from the former year) and revenue of $3.81 billion (a 1.6% increase). Analyst sentiment, as reflected by the Zacks Consensus EPS estimate, has remained unchanged over the last 30 days, contributing to Diebold Nixdorf's current Zacks Rank of #3 (Hold). Valuation metrics reveal a Forward P/E ratio of 14.4 for DBD, which represents a significant discount compared to its industry average Forward P/E of 45.44. The company is part of the Internet - Software industry, which boasts a Zacks Industry Rank of 47, placing it in the top 20% of over 250 industries tracked.

Key Decisions for Investors

• Investors should closely scrutinize the upcoming earnings report for clarifications on the drivers of the anticipated full-year EPS growth of +57.27%, particularly in light of the expected sharp decline in quarterly EPS of -47.41% and revenue of -5.7%.
• The current Zacks Rank #3 (Hold) and unchanged consensus EPS estimates suggest a cautious approach; however, the stock's Forward P/E of 14.4, substantially below the industry average of 45.44, may offer a value consideration if the company demonstrates a clear path to achieving its full-year growth targets.
• Consider DBD's recent outperformance, with a +4.07% gain in the past month against broader market and sector weakness, but weigh this positive momentum against the immediate-term headwinds indicated by the quarterly earnings and revenue projections.